Singapore Pharmaceutical Market Growth, Demand and Challenges of the Key Industry Players 2024-2032 - PowerPoint PPT Presentation

About This Presentation
Title:

Singapore Pharmaceutical Market Growth, Demand and Challenges of the Key Industry Players 2024-2032

Description:

According to the latest research report by IMARC Group, The Singapore pharmaceutical market size is projected to exhibit a growth rate (CAGR) of 5.70% during 2024-2032. More Info:- – PowerPoint PPT presentation

Number of Views:0
Date added: 9 July 2024
Slides: 15
Provided by: MarcelMikaelson
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Singapore Pharmaceutical Market Growth, Demand and Challenges of the Key Industry Players 2024-2032


1
Singapore Pharmaceutical Market Research and
Forecast Report 2024-2032
  • Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group
  • International Market Analysis Research and
    Consulting Group is a leading adviser on
    management strategy and market research
    worldwide. We partner with clients in all regions
    and industry verticals to identify their
    highest-value opportunities, address their most
    critical challenges, and transform their
    businesses.
  • IMARCs information products include major
    market, scientific, economic and technological
    developments for business leaders in
    pharmaceutical, industrial, and high technology
    organizations. Market forecasts and industry
    analysis for biotechnology, advanced materials,
    chemicals, food and beverage, travel and tourism,
    nanotechnology and novel processing methods are
    at the top of the companys expertise.
  • IMARCs tailored approach combines unfathomable
    insight into the dynamics of companies and
    markets with close cooperation at all levels of
    the client organization. This ensures that our
    clients achieve unmatchable competitive
    advantage, build more proficient organizations,
    and secure lasting results.

3
Report Highlight and Description
  • According to the latest report by IMARC Group,
    titled "Singapore Pharmaceutical Market Industry
    Trends, Share, Size, Growth, Opportunity and
    Forecast 2024-2032," the Singapore pharmaceutical
    market size is projected to exhibit a growth rate
    (CAGR) of 5.70 during 2024-2032.
  • Singapore Pharmaceutical Market Trends and
    Drivers
  • Rise of Biologics and Biosimilars
  • The Singapore pharmaceutical market is witnessing
    a significant shift towards biologics and
    biosimilars, driven by advancements in
    biotechnology and a growing demand for
    personalized medicine. Biologics, which are
    complex molecules derived from living cells,
    offer targeted therapies for conditions such as
    cancer, autoimmune diseases, and genetic
    disorders. The Singapore governments support for
    biopharmaceutical innovation, through initiatives
    like the Biomedical Sciences Industry Partnership
    Office (BMS IPO), has encouraged both local and
    international companies to invest in biologics
    research and development. Biosimilars, which are
    similar to existing biologic drugs, are gaining
    traction as cost-effective alternatives,
    especially in a market where healthcare costs are
    a major concern. Regulatory bodies in Singapore,
    such as the Health Sciences Authority (HSA), have
    streamlined the approval process for biosimilars,
    ensuring that they meet rigorous safety and
    efficacy standards. The increasing adoption of
    biologics and biosimilars is also fueled by the
    growing prevalence of chronic diseases and the
    need for more effective and sustainable treatment
    options. This trend is expected to continue,
    driven by ongoing research and the entry of new
    players in the biologics space, thereby enhancing
    the therapeutic landscape and expanding market
    opportunities.

4
Report Highlight and Description
  • Digital Health Integration and E-Pharmacy
    Expansion
  • Digital health technologies and e-pharmacy
    platforms are revolutionizing the pharmaceutical
    landscape in Singapore. The integration of
    digital health tools, such as telemedicine,
    electronic health records (EHRs), and mobile
    health applications, is enhancing patient care
    and streamlining pharmaceutical services.
    Telemedicine has seen a substantial increase in
    adoption, particularly during the COVID-19
    pandemic, enabling patients to consult with
    healthcare professionals remotely and access
    medications conveniently. E-pharmacy platforms
    are gaining popularity as they offer home
    delivery services, ensuring that patients receive
    their medications promptly without the need to
    visit physical pharmacies. These platforms also
    provide value-added services such as medication
    reminders, online consultations, and personalized
    health advice. The Singapore governments push
    towards a Smart Nation and the increasing
    penetration of internet and smartphone usage
    further support the growth of digital health
    solutions. Additionally, collaborations between
    pharmaceutical companies and tech firms are
    leading to innovative solutions that improve
    medication adherence, patient engagement, and
    overall healthcare outcomes. The shift towards
    digital health and e-pharmacy not only enhances
    accessibility and convenience for patients but
    also helps in better management of healthcare
    resources and data, contributing to the overall
    efficiency of the healthcare system.
  • Request for a PDF sample of this report
    https//www.imarcgroup.com/singapore-pharmaceutica
    l-market/requestsample

5
Report Description
  • Singapore Pharmaceutical Market Trends
  • The Singapore pharmaceutical market is driven by
    several key factors, including the country's
    robust healthcare infrastructure, government
    support for biomedical research, and a strategic
    focus on innovation and technology. Singapore's
    government has invested heavily in transforming
    the country into a biomedical hub through
    initiatives like the Research, Innovation and
    Enterprise 2020 (RIE2020) plan, which allocates
    substantial funding for scientific research.
    Additionally, the presence of leading global
    pharmaceutical companies and research
    institutions in Singapore fosters a conducive
    environment for pharmaceutical advancements.
  • The country's strategic location in Asia also
    makes it an attractive hub for clinical trials
    and pharmaceutical manufacturing, benefiting from
    efficient regulatory frameworks and strong
    intellectual property protections. With an aging
    population and rising prevalence of chronic
    diseases, there is an increasing demand for
    innovative and high-quality pharmaceuticals.
    Moreover, Singapore's commitment to maintaining
    high standards in healthcare services and its
    proactive approach to healthcare challenges
    further enhance its market attractiveness.
  • View Report TOC, Figures and Tables
    https//www.imarcgroup.com/singapore-pharmaceutica
    l-market

6
Report Segmentation
  • Type Insights
  • Pharmaceutical Drugs
  • Cardiovascular Drugs
  • Dermatology Drugs
  • Gastrointestinal Drugs
  • Genito-Urinary Drugs
  • Hematology Drugs
  • Anti-Infective Drugs
  • Metabolic Disorder Drugs
  • Musculoskeletal Disorder Drugs
  • Central Nervous System Drugs
  • Oncology Drugs
  • Ophthalmology Drugs
  • Respiratory Diseases Drugs
  • Biologics
  • Monoclonal Antibodies (MAbS)

7
Report Segmentation
  • Therapeutic Proteins
  • Vaccines
  • Nature Insights
  • Organic
  • Conventional
  • Regional Insights
  • North-East
  • Central
  • West
  • East
  • North

8
Key Questions Answered in the Report
9
Table of Contents
  • 1    Preface2    Scope and Methodology    2.1  
     Objectives of the Study    2.2  
     Stakeholders    2.3    Data Sources       
    2.3.1    Primary Sources        2.3.2  
     Secondary Sources    2.4    Market Estimation 
          2.4.1    Bottom-Up Approach        2.4.2  
     Top-Down Approach    2.5    Forecasting
    Methodology3    Executive Summary4 Singapore
    Pharmaceutical Market Introduction
  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence
  • 5 Singapore Pharmaceutical Market Landscape
  • 5.1 Historical and Current Market Trends
    (2018-2023)
  • 5.2 Market Forecast (2024-2032)
  • 6 Singapore Pharmaceutical Market - Breakup by
    Type
  • 6.1 Pharmaceutical Drugs
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends
    (2018-2023)
  • 6.1.3 Market Segmentation
  • 6.1.3.1 Cardiovascular Drugs
  • 6.1.3.2 Dermatology Drugs
  • 6.1.3.3 Gastrointestinal Drugs
  • 6.1.3.4 Genito-Urinary Drugs
  • 6.1.3.5 Hematology Drugs
  • 6.1.3.6 Anti-Infective Drugs       

10
Table of Contents
  • 6.1.3.7 Metabolic Disorder Drugs
  • 6.1.3.8 Musculoskeletal Disorder Drugs
  • 6.1.3.9 Central Nervous System Drugs
  • 6.1.3.10 Oncology Drugs
  • 6.1.3.11 Ophthalmology Drugs
  • 6.1.3.12 Respiratory Diseases Drugs
  • 6.1.4 Market Forecast (2024-2032)
  • 6.1.5 Market Breakup by Nature
  • 6.2 Biologics
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends
    (2018-2023)
  • 6.2.3 Market Segmentation
  • 6.2.3.1 Monoclonal Antibodies (MAbS)
  • 6.2.3.2 Therapeutic Proteins
  • 6.2.3.3 Vaccines
  • 6.2.4 Market Forecast (2024-2032)
  • 6.2.5 Market Breakup by Nature
  • 6.3 Attractive Investment Proposition by Type
  • 7 Singapore Pharmaceutical Market - Breakup by
    Nature

11
Partial List of Clients
12
Partial List of Clients
13
Disclaimer
  • 2024 IMARC All Rights Reserved
  • This Publication and all its contents unless
    otherwise mentioned are copyrighted in the name
    of International Market Analysis Research and
    Consulting (IMARC). No part of this publication
    may be reproduced, repackaged, redistributed or
    resold in whole or in any part. The publication
    may also not be used in any form or by and means
    graphic electronic or mechanical, including
    photocopying, recording, taping or by information
    storage or retrieval, or by any other form,
    without the express consent of International
    Market Analysis Research and Consulting (IMARC).
  • Disclaimer All contents and data of this
    publication, including forecasts, data analysis
    and opinion have been based on information and
    sources believed to be accurate and reliable at
    the time of publishing. International Market
    Analysis Research and Consulting makes no
    representation of warranty of any kind as to the
    accuracy or completeness of any Information
    provided. IMARC accepts no liability whatsoever
    for any loss or damage resulting from opinion,
    errors or inaccuracies if any found this
    publication.
  • IMARC, IMARC Group and Global Therapy Insight
    Series are registered trademarks of International
    Market Analysis Research and Consulting. All
    other trademarks used in this publication are
    registered trademarks of their respective
    companies.

14
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us
Write a Comment
User Comments (0)
About PowerShow.com